oxidised glutathione glucose 6 phosphate dehydrogenase defciency Glucose-6-Phosphate Deficiency and Cardiovascular Risk in Familial Hypercholesterolemia: A Retrospective Cohort Study Glucose-6-phosphate dehydrogenase deficiency - The
Description
Details SHOW SMILES / InChI SMILES OP(O)(O)=O.CC(C)CCNC1=C(C=CC=N1)C(=O)N2CCN(CC3=CC=CC=C3)CC2 InChI InChIKey=LWHMGALTTIYPJU-UHFFFAOYSA-N InChI=1S/C22H30N4O.H3O4P/c1-18(2)10-12-24-21-20(9-6-11-23-21)22(27)26-15-13-25(14-16-26)17-19-7-4-3-5-8-19;1-5(2,3)4/h3-9,11,18H,10,12-17H2,1-2H3,(H,23,24);(H3,1,2,3,4) NSI-189 is a novel oral drug which was developed by Neuralstem for the treatment of cognitive disorders
60073-2/asset/67a8baac-51a2-4f83-92b3-762e1e57d1f5/main.assets/gr1_lrg.jpg)
Glioblastoma and other malignant gliomas: A clinical review

Nausea 16-46%, diarrhea 16-26%, vomiting 8-22%

How can we put this number in perspective
